Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma

Annals of Hematology

Volumn 89, Issue 8, 2010, Pages 775-782

  Cvetković, Zorica ^a   Vučić, Vesna ^b   Cvetković, Bora ^a   Petrović, Milan ^c   Ristić Medić, Danijela ^b   Tepšić, Jasna ^b   Glibetić, Maria ^b  

^a Clinical Hospital Center Zemun   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Fatty acids; Non Hodgkin lymphoma; Serum phospholipids

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; ADRENIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; MONOUNSATURATED FATTY ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID;

ADULT; AGED; ARTICLE; BODY FAT DISTRIBUTION; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; LIPID COMPOSITION; MALE; NONHODGKIN LYMPHOMA; NUTRITIONAL ASSESSMENT; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; BLOOD; DIET; MIDDLE AGED; QUESTIONNAIRE;

ADULT; AGED; DIET; FATTY ACIDS; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PHOSPHOLIPIDS; QUESTIONNAIRES; YOUNG ADULT;

EID: 77954662882     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-0904-6     Document Type: Article

References (43)

1. Müller AMS, Ihorst G, Mertelsmann R, Engelhardt M (2005) Epidemiology of non-Hodgkin's lymphoma (NHL): Trends, geographic distribution, and etiology. Ann Hematol 84:1-12
2. Zheng T, Holford TR, Leaderer B, Zhang Y, Zahm SH, Flynn S, Tallini G, Zhang B, Zhou K, Owens PH, Lan Q, Rothman N, Boyle P (2004) Diet and nutrient intakes and risk of non- Hodgkin's lymphoma in Connecticut women. Am J Epidemiol 159:454-466
3. Purdue MP, Bassani DG, Klar NS, Sloan M, Krieger N, The Canadian Cancer Registries Epidemiology Research Group (2004) Dietary factors and risk of non-Hodgkin lymphoma by histologic subtype: A case-control analysis. Cancer Epidemiol Biomark Prev 13:1665-1676
4. Zhang S, Hunter DJ, Rosner BA, Colditz GA, Fuchs CS, Speizer FE, Willet WC (1999) Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst 91:1751-1758
5. Polesel J, Talamini R, Montella M, Parpinel M, Dal Maso L, Crispo A, Crovatto M, Spina M, La Vecchia C, Franceschi S (2006) Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: An Italian case-control study. Ann Oncol 17:713-718
6. Kato I, Akhmedkhanov A, Koenig K, Toniolo PG, Shore RE, Riboli E (1997) Prospective study of diet and female colorectal cancer: The New York University Women's Health Study. Nutr Cancer 28:276-281
7. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE (1990) Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323:1664-1672
8. Fritschi L, Ambrosini GL, Kliewer EV, Johnson KC (2004) Dietary fish intake and risk of leukaemia, multiple myeloma, and non-Hodgkin lymphoma cancer. Epidemiol Biomarkers Prev 13:532-537
9. Chaudry A, McClinton S, Moffat LE, Wahle KW (1991) Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease. Br J Cancer 64:1157-1160
10. Crowe FL, Allen NE, Appleby PN et al (2008) Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88 (5):1353-1363
11. Chajes V, Hulten K, Kappel ALV, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E (1999) Fatty-acids composition in serum phospholipids and risk of breast cancer: An incident case-control study in Sweden. Int J Cancer 83:585-590 (Pubitemid 29508033)
12. Lisboa AQ, Rezende M, Muniz-Junqueira MI, Ito MK (2008) Altered plasma phospholipid fatty acids and nutritional status in patients with uterine cervical cancer. Clin Nutr 27:371-377
13. van Leeuwen SDZ, van der Heijden MS, Rietveld T, van den Berg JW, Tilanus HW, Burgers JA, Wilson JH, Dagnelie PC (2002) Fatty acids composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin Nutr 21:225-230
14. Pratt VC, Watanabe S, Bruera E, Mackey J, Clandinin MT, Baracos VE, Field CJ (2002) Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer 87:1370-1378
15. Harris NL, Stein H, Coupland SE, Hummel M, Dalla Favera R, Pasqualucci L, Chan WC (2001) New approaches to lymphoma diagnosis. Hematology 1:194-220
16. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861
17. Zilversmit DB, Davis AK (1950) Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med 35:155-160
18. Matusik EJ, Reeves VB, Flanagan VP (1984) Determination of fatty acid methyl esters. Anal Chim Acta 166:179-188
19. Tepšic J, Vucic V, Arsic A, Blažencic-Mladenovic V, Mazic S, Glibetic M (2009) Plasma and erythrocyte phospholipid fatty acid profile in professional basketball and football players. Eur J Appl Physiol 107:359-365
20. Popovic T, Ranic M, Bulajic P, Milicevic M, Arsic A, Vucic V, Glibetic M (2009) Effects of n-3 fatty acids supplementation on plasma phospholipids fatty acid composition in patients with obstructive jaundice-a pilot study. J Clin Biochem Nutr 45:1-6
21. Cvetkovic Z, Cvetkovic B, Petrovic M, Ranic M, Debeljak- Martarcic J, Vucic V, Glibetic M (2009) Lipid profile as a prognostic factor in cancer patients. J BUON 14:501-506
22. McClinton S, Moffat LE, Horrobin DF, Manku MS (1991) Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer 63:314-316
23. Taylor DD, Gercel-Taylor C, Jenis L, Devereux DF (1992) Identification of a human tumor-derived lipolysis-promoting factor. Cancer Res 52:829-834
24. Douglas RG, Shaw JH (1990) Metabolic effects of cancer. Br J Surg 77:246-254
25. Murphy RA, Wilke MS, Perrine M, Pawlowicz M, Mourtzakis M, Lieffers JR, Maneshgar M, Bruera E, Clandinin MT, Baracos VE, Mazurak VC (2009) Loss of adipose tissue and plasma phospholipids: Relationship to survival in advanced cancer patients. Clin Nutr. doi:10.1016/j.clnu.2009.11.006
26. Grunfeld C, Feingold KR (1996) Regulation of lipid metabolism by cytokines during host defense. Nutrition 12:S24-S26
27. Fernandez E, Chatenoud L, La Vecchia C, Negri E, Franceschi S (1999) Fish consumption and cancer risk. Am J Clin Nutr 70:85-90
28. Terry PD, Rohan TE, Wolk A (2003) Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: A review of the epidemiological evidence. Am J Clin Nutr 77:532-543
29. Deckere EA (1999) Possible beneficial effect of fish and fish n-3 polyunsaturated fatty acids in breast and colorectal cancer. Eur J Cancer Prev 8:213-221
30. Xia SH, Wang J, Kang JX (2005) Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes. Carcinogenesis 26(4):779-784
31. Field CJ, Schley PD (2004) Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: Lessons from n-3 fatty acids. Am J Clin Nutr 79:1190S-1198S
32. Whelan J, McEntee MF (2004) Dietary (n-6) PUFA and intestinal tumorigenesis. J Nutr 134:3421S-3426S
33. Ristic-Medic D, Suzic S,VucicV, TakicM, Tepsic J,GlibeticM(2009) Serum and erythrocyte membrane phospholipid fatty acid composition in hiperlipidemia: Effects of dietary intervention and combined diet and fibrate therapy. Gen Physiol Biophys, Spec Issue 28:190-199
34. Pandey M, Khatry AK, Dubey SS, Gautam A, Shukla VK (1995) Erythrocyte-membrane fatty-acid profile in patients with primary carcinoma of the gallbladder. J Surg Oncol 59:31-34
35. Persad RA, Gillatt DA, Heinemann D, Habib NA, Smith PJ (1990) Erythrocyte stearic to oleic acid ratio in prostatic carcinoma. Brit J Urol 65:268-270
36. Evans LM, Cowey SL, Siegal GP, Hardy RW (2009) Stearate preferentially induces apoptosis in human breast cancer cells. Nutr Cancer 61:746-753
37. Fermor BF, Masters JRW, Wood CB, Miller J, Apostolov K, Habib NA (1992) Fatty-acid composition of normal and malignant cells and cytotoxicity of stearic, oleic and sterculic acids in vitro. Eur J Cancer 28A:1143-1147
38. Chiu BCH, Cerhan JR, Folsom AR, Sellers TA, Kushi LH, Wallace RB, Zheng W, Potter JD (1996) Diet and risk of non-Hodgkin's lymphoma in older women. JAMA 276:1315-1321
39. Rakheja D, Kapur P, Hoang MP, Roy LC, Bennett MJ (2005) Increased ratio of saturated to unsaturated C18 fatty acids in colonic adenocarcinoma: Implications for cryotherapy and lipid raft function. Med Hypotheses 65:1120-1123
40. Kuhajda FP, Jenner K, Wood FD, Henningar RA, Jacobs LB, Dick JD, Pasternack GR (1994) Fatty acid synthesis: A potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 91:6379-6383
41. Pala V, Krogh V, Muti P, Chajès V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F (2001) Erythrocyte membrane fatty acids and subsequent breast cancer: A prospective Italian study. JNCI 93 (14):1088-1095
42. Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, González MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W (2004) Cell membrane fatty acid composition differs between normal and malignant cell lines. P R Health Sci J 23:103-106
43. Agatha G, Hafer R, Zintl F (2001) Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. Cancer Lett 173:139-144